INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/04/2025
Back to search
Official data from USPTO
PHARMA TRAIN MASTERING MEDICINES DEVELOPMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/05/2025
Classification
Registered
Trademark type
Combined
Nice classes
9, 41, 42
Filing date
09/20/2012
Registration date
10/22/2013
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2024
Last transaction
04/05/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
BE
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the wording "PHARMA TRAIN" in large font above the wording "MASTERING MEDICINES DEVELOPMENT" which appears in smaller font. Six stars appear in a curve below the letter "P" in "PHARMA".
Holders and representatives
Holders
P. A. (pessoa física)
PharmaTrain Federation c/o ECPM EuropeanCenter of Pharmaceutical Medicine Universität Basel
PharmaTrain Federation; c/o ECPM European Center of; Pharmaceutical Medicine; Universität Basel
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 9Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic teaching materials in the field of pharmaceutical medicinepharmaceutical biology and pharmacy
Class 41
Academic training in the field of pharmaceutical medicinepharmaceutical biology and pharmacy; Providing online websites and non-downloadable teaching materials all featuring educational coursework in the field of pharmaceutical medicinepharmaceutical biology and pharmacy
Class 42
Development of electronic teaching software in the field of pharmaceutical medicinepharmaceutical biology and pharmacy; development of quality control standards for teaching in the field of pharmaceutical medicinepharmaceutical biology and pharmacy
Publications
History of USPTO decisions and trademark events.
41 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/17/2025
INPC
INVALIDATION PROCESSED
03/17/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/04/2025
C71T
CANCELLED SECTION 71
05/03/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/27/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/22/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/15/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/11/2020
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
02/11/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/07/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
11/26/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/25/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
10/22/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/16/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/23/2014
FIMP
FINAL DISPOSITION PROCESSED
01/23/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2013
PUBO
PUBLISHED FOR OPPOSITION
08/06/2013
NPUB
NOTICE OF PUBLICATION
07/17/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/02/2013
ALIE
ASSIGNED TO LIE
06/26/2013
CNEA
EXAMINERS AMENDMENT MAILED
06/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2013
RFNT
REFUSAL PROCESSED BY IB
02/14/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2013
RFRR
REFUSAL PROCESSED BY MPU
01/22/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/19/2013
CNRT
NON-FINAL ACTION WRITTEN
01/18/2013
DOCK
ASSIGNED TO EXAMINER
01/18/2013
MAFR
APPLICATION FILING RECEIPT MAILED
01/01/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2012
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/20/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/20/2012
Continuous trademark protection
Get notified about every new filing that threatens PHARMA TRAIN MASTERING MEDICINES DEVELOPMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.